Training
Module 2 - Quality
- Report to the VOF on the withdrawal periods for veterinary medicinal products – Approach by VICH members and observers (final – August 2020)
- VICH GL1 and GL2: Validation of analytical procedures
- VICH Guidelines on Stability: Overview (English) – Vue d'ensemble (French)
- VICH GL3 (R) & 4 – Stability testing of new veterinary drug substances and medicinal products + Annex GL4 – Requirements for new dosage forms
- VICH GL5 – Photostability testing of new veterinary drug substances and medicinal products
- VICH GL8 (R) – Stability testing for medicated premixes
- VICH GL10: Impurities – GL on impurities in new veterinary drug substances
- VICH GL11: Impurities: GL on impurities in new veterinary medicinal products
- VICH GL18 (R): Impurities: Residual solvents in new veterinary medicinal products, active substance and excipients
- VICH GL39: Specifications-pharmaceuticals
- VICH GL45 (R) – Bracketing and matrixing designs for stability testing of new veterinary drug substances and medicinal products
- VICH GL51 – Statistical evaluation of stability data
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.